Wolf Ido, Sadetzki Siegal, Gluck Iris, Oberman Bernice, Ben-David Merav, Papa Moshe Zvi, Catane Raphael, Kaufman Bella
The Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel.
Eur J Cancer. 2006 May;42(8):1077-82. doi: 10.1016/j.ejca.2006.01.027. Epub 2006 Mar 29.
Type 2 diabetes mellitus is associated with increased incidence and inferior outcome of various malignancies. The aim of this study was to explore the impact of type 2 diabetes on breast cancer characteristics at presentation. The study population included 79 diabetic and 158 age-matched non-diabetic patients. Parity, country of birth, co-morbidity other than diabetes, and mode of diagnosis were similar in both groups. Mean body mass index (BMI) was higher among diabetic patients. Tumour stage and size were higher among diabetic patients and the differences remained significant after adjustment for BMI. Moreover, after adjustment for BMI, breast cancer among diabetic patients was more often hormone receptor negative. Our results show that diabetes mellitus is associated with negative prognostic factors at breast cancer presentation.
2型糖尿病与多种恶性肿瘤的发病率增加及预后较差有关。本研究的目的是探讨2型糖尿病对乳腺癌初诊时特征的影响。研究人群包括79名糖尿病患者和158名年龄匹配的非糖尿病患者。两组在产次、出生国家、除糖尿病外的合并症以及诊断方式方面相似。糖尿病患者的平均体重指数(BMI)较高。糖尿病患者的肿瘤分期和大小更高,在对BMI进行调整后,差异仍然显著。此外,在对BMI进行调整后,糖尿病患者中的乳腺癌更常为激素受体阴性。我们的结果表明,糖尿病与乳腺癌初诊时的不良预后因素有关。